Log In or Create Account
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
Advanced Search
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Menu
Topics in Antiviral Medicine
™
June/July 2024
Volume 32, Issue 3
Download here
, or select individual articles
Claim CME
Selected Highlights of the 2024 Conference on Retroviruses and Opportunistic Infections
CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases
Albert Y. Liu, MD, MPH, Susan P. Buchbinder, MD
CROI 2024: Summary of Basic Science Research in HIV
Mario Stevenson, PhD
CROI 2024: Tuberculosis, Mpox, and Other Infectious Complications in People With HIV
Andrew D. Kerkhoff, MD, PhD, Jason Zucker, MD, Diane V. Havlir, MD
CROI 2024: Metabolic and Other Complications of HIV Infection
Sudipa Sarkar, MD, Todd T. Brown, MD, PhD
Topics in Antiviral Medicine™
Current Issues
Previous Issues
TAM
Policies and Practices
TAM
Author and Contributor Guidelines
Topics in Antiviral Medicine
Editorial Board
CROI
Conference on Bacteriophages
RWHAP Clinical Conference
Podcasts
Slides
Question of the Week
Donate
Contact
CME Courses
HIV In-Person and Virtual Courses
Current On-Demand Courses
About Courses
CME Webinars
Upcoming Webinars
Current On-Demand Webinars
MATE Act CME
About Webinars
Dialogues
Upcoming IAS–USA Dialogues
On-Demand Dialogues
About Dialogues
Topics In Antiviral Medicine
Current Issues for CME
Previous Issues
TAM
Policies and Practices
Permission Request Form
HIV Drug Resistance
Drug Resistance Mutations Chart
Recent Webinars
Journal Articles
Fellow Resources
Fellow Resources
IAS-USA Guidelines and Recommendations
On-Demand Webcasts
Research Collaborations
Additional Resources
About
Scientific Leadership Board
IAS-USA Leadership Award Recipients
Core Faculty
Mission
Staff
CME
Funding Information
Careers
Website Policies
Governance
Suggestions and Recommendations from San Francisco Locals
FAQs
Practice Question of the Week
June 9, 2025: Drug-Drug Interactions Between Antiretroviral Therapy and Antimalarial Drugs
Which of the following statements is TRUE?
A. No antimalarial drug can safely be used with cabotegravir
B. Ritonavir reduces atovaquone-proguanil levels, but no clinical effect has been demonstrated
C. Integrase strand transfer inhibitors have significant interactions with several antimalarial drugs
D. Mefloquine is the antimalarial drug least likely to interact with typical antiretroviral regimens
View the On-Demand Webinar
View Archived Questions
Leave Feedback
Subscribe
CLOSE
